Complete Filing Data
SINOVAC BIOTECH LTD reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $12.02 billion for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean SINOVAC BIOTECH LTD did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$99.9M | $113.9M | $8.47B | $110.4M | $44.9M | $21.8M | $25.8M | -$720.0K | -$957.0K | -$1.2M | $10.4M | -$18.7M | -$844.7K | -$8.5M | $20.0M |
| Revenue * | $448.3M | $1.49B | $19.37B | $510.6M | $246.1M | $229.7M | $3.9M | $72.4M | $67.4M | $62.9M | $71.8M | $49.2M | $56.8M | $33.4M | $84.2M |
| Selling General And Administrative Expense | $466.3M | $823.5M | $591.2M | $176.5M | $121.5M | $137.0M | $87.4M | $42.0M | $37.5M | $34.3M | $33.6M | $33.3M | $23.8M | $18.9M | $18.2M |
| Research And Development Expense | $344.5M | $442.1M | $155.0M | $48.8M | $24.3M | $21.9M | $20.5M | $12.6M | $9.5M | $10.9M | $8.1M | $17.0M | $9.0M | $8.5M | $4.4M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$106.8M | -$513.9M | $110.7M | $24.2M | -$2.2M | -$9.2M | $6.9M | -$8.0M | -$3.8M | -$2.1M | $2.4M | $1.8M | $3.1M | $2.7M | $82.0K |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest | -$107.7M | -$345.1M | $82.4M | $8.1M | -$605.0K | -$1.8M | $1.2M | -$829.0K | -$541.0K | -$305.0K | $316.0K | $231.0K | $528.0K | -$889.0K | -$17.5K |
| Operating Income Loss | -$603.0M | -$466.1M | $17.55B | $215.6M | $68.6M | $45.3M | $45.4M | $504.0K | $3.7M | $1.9M | $9.9M | -$21.2M | $3.4M | -$12.1M | $42.1M |
| Operating Expenses | $869.8M | $1.27B | $749.4M | $227.8M | $145.0M | $159.6M | $108.7M | $49.5M | $45.3M | $45.6M | $41.3M | $51.3M | $32.3M | $28.8M | $22.0M |
| Net Income Loss Available To Common Stockholders Basic | -$105.9M | $107.9M | $8.46B | $104.4M | $39.8M | $21.8M | $25.8M | -$596.0K | -$1.4M | -$1.5M | $7.4M | -$14.9M | -$844.0K | -$8.5M | $20.0M |
| Net Income Loss Attributable To Noncontrolling Interest | -$158.4M | -$25.7M | $5.99B | $74.8M | $20.3M | $14.3M | $10.9M | -$124.0K | $459.0K | $270.0K | $2.9M | -$3.9M | $445.0K | $4.1M | -$10.5M |
| Income Tax Expense Benefit | $105.3M | -$62.9M | $3.10B | $31.4M | $5.6M | $10.5M | $8.3M | $2.7M | $3.0M | $2.1M | -$2.2M | -$884.0K | $5.1M | -$703.9K | $11.1M |
| Gross Profit | $266.8M | $808.3M | $18.30B | $443.4M | $213.6M | $204.9M | $154.1M | $50.0M | $49.0M | $47.5M | $51.3M | $30.1M | $35.7M | $16.7M | $64.1M |
| Deferred Income Tax Expense Benefit | $76.3M | -$83.0M | $265.1M | -$11.2M | -$5.7M | $3.1M | -$4.9M | -$1.0M | -$333.0K | -$225.0K | -$2.2M | -$17.0K | $2.8M | -$1.7M | $1.3M |
| Cost Of Revenue | $181.5M | $684.5M | $1.07B | $67.2M | $32.5M | $24.7M | $20.2M | $22.4M | $18.4M | $15.5M | $20.5M | $19.1M | $21.1M | $16.7M | $20.1M |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$266.2M | -$370.9M | $6.07B | $82.9M | $19.7M | $12.5M | $12.1M | -$953.0K | -$82.0K | -$35.0K | $3.2M | -$3.7M | $973.0K | -$3.2M | $10.5M |
| Comprehensive Income Net Of Tax | -$206.7M | -$400.0M | $8.58B | $134.6M | $42.7M | $12.6M | $32.7M | -$8.6M | -$5.3M | -$3.6M | $9.8M | -$13.1M | $2.3M | -$5.8M | $20.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$153.0M | $25.2M | $17.56B | $216.6M | $70.8M | $46.6M | $45.0M | -$394.0K | $2.8M | $2.3M | $9.4M | -$19.6M | $4.7M | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | -$472.9M | -$770.9M | $14.65B | $217.5M | $62.4M | $25.1M | $44.8M | -$9.6M | -$5.3M | -$3.6M | $13.1M | -$16.7M | $3.2M | ||
| Income Taxes Paid | $1.32B | $1.49B | $11.2M | $7.3M | $19.2M | $7.9M | $1.9M | $2.1M | $491.0K | $0.00 | $2.3M | $882.0K | $6.0M | $3.1M | |
| Interest Expense Related Party | $354.0K | $916.0K | $663.0K | $455.0K | $453.0K | $262.0K | $176.0K | $183.0K | $221.0K | $237.0K | $231.0K | ||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$280.4M | -$859.0M | $193.1M | $32.3M | -$2.8M | -$11.0M | $8.1M | -$4.0M | -$2.3M | $2.7M | $2.0M | $3.6M | |||
| Income Loss From Continuing Operations Per Diluted Share | $0.34 | $0.45 | -$0.05 | -$0.02 | $0.00 | $0.15 | |||||||||
| Income Loss From Continuing Operations Per Basic Share | $0.34 | $0.45 | -$0.05 | -$0.02 | $0.00 | $0.15 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $8.71B | $8.92B | $9.33B | $746.5M | $294.0M | $253.4M | $151.2M | $115.8M | $121.7M | $126.6M | $128.7M | $117.7M | $129.9M | $126.4M | $84.5M | $56.9M |
| Cash And Cash Equivalents At Carrying Value | $1.27B | $4.28B | $11.61B | $1.04B | $152.7M | $158.2M | $114.4M | $62.4M | $63.8M | $89.8M | $106.5M | $91.2M | $104.3M | $101.6M | $75.0M | $32.9M |
| Inventory Write Down | $52.5M | $140.0M | $70.1M | $5.8M | $651.0K | $2.5M | $1.2M | $6.4M | $1.8M | $1.0M | $1.1M | $3.5M | $4.0M | $6.8M | $593.5K | |
| Interest And Debt Expense | $2.3M | $1.3M | $2.8M | $1.5M | $650.0K | $1.1M | $1.6M | $1.7M | $1.9M | $3.4M | $3.0M | $775.0K | $384.0K | $1.2M | $534.5K | |
| Repayments Of Debt | $308.0K | $3.0M | $33.4M | $6.0M | $3.3M | $43.9M | $38.7M | $24.9M | $46.8M | $16.0M | $4.1M | $4.8M | $10.7M | |||
| Accounts Payable And Accrued Liabilities Current | $973.9M | $905.9M | $1.02B | $211.4M | $58.9M | $50.0M | $59.4M | $25.0M | $22.7M | -$3.5M | $28.0M | $24.8M | $29.5M | $22.1M | ||
| Property Plant And Equipment Net | $979.6M | $993.8M | $903.3M | $200.4M | $74.3M | $70.9M | $76.4M | $66.9M | $63.9M | $66.2M | $68.0M | $69.2M | $75.6M | $64.0M | ||
| Prepaid Expense And Other Assets Current | $11.6M | $15.2M | $161.0M | $15.5M | $1.9M | $4.5M | $2.1M | $1.4M | $958.0K | $1.4M | $1.2M | $1.1M | $1.8M | $887.2K | ||
| Minority Interest | $3.31B | $3.79B | $4.55B | $373.7M | $58.2M | $38.5M | $26.0M | $13.9M | $14.9M | $15.2M | $15.0M | $11.7M | $15.4M | $21.3M | ||
| Liabilities Noncurrent | $487.3M | $310.3M | $459.3M | $101.6M | $12.9M | $19.6M | $29.5M | $15.4M | $8.3M | $17.0M | $47.9M | $49.2M | $30.0M | $20.8M | ||
| Liabilities Current | $1.15B | $1.09B | $2.41B | $679.6M | $87.2M | $58.2M | $92.5M | $66.3M | $58.1M | $79.8M | $49.2M | $30.2M | $40.6M | $45.8M | ||
| Liabilities And Stockholders Equity | $13.66B | $14.11B | $16.75B | $1.90B | $452.3M | $369.8M | $299.2M | $211.4M | $202.9M | $238.5M | $240.7M | $208.8M | $215.9M | $214.4M | ||
| Liabilities | $1.64B | $1.40B | $2.87B | $781.2M | $100.1M | $77.9M | $122.1M | $81.7M | $66.4M | $96.8M | $97.1M | $79.3M | $70.6M | $66.6M | ||
| Inventory Net | $139.9M | $180.7M | $375.5M | $105.8M | $27.8M | $25.1M | $19.6M | $14.1M | $18.7M | $18.7M | $14.3M | $10.5M | $8.1M | $14.5M | ||
| Deferred Government Grants Noncurrent | $5.9M | $4.5M | $4.9M | $4.2M | $4.0M | $6.0M | $4.5M | $3.0M | $4.7M | $7.5M | $4.7M | $4.1M | $2.3M | $2.5M | ||
| Common Stock Value | $100.0K | $100.0K | $100.0K | $99.0K | $99.0K | $71.0K | $57.0K | $57.0K | $57.0K | $56.0K | $56.0K | $55.0K | $54.8K | $54.3K | ||
| Assets Current | $11.83B | $12.13B | $14.92B | $1.56B | $349.6M | $284.2M | $203.9M | $130.7M | $128.5M | $154.8M | $157.3M | $126.3M | $132.0M | $147.0M | ||
| Assets | $13.66B | $14.11B | $16.75B | $1.90B | $452.3M | $369.8M | $299.2M | $211.4M | $202.9M | $238.5M | $240.7M | $208.8M | $215.9M | $214.4M | ||
| Additional Paid In Capital Common Stock | $541.3M | $540.6M | $547.7M | $538.9M | $208.0M | $205.0M | $115.3M | $112.7M | $109.9M | $108.2M | $107.4M | $106.2M | $105.4M | $104.2M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$490.1M | -$383.3M | $130.6M | $19.9M | -$4.3M | -$2.1M | $7.1M | $168.0K | $8.2M | $12.0M | $14.1M | $11.8M | $10.0M | $6.9M | ||
| Accounts Receivable Net Current | $440.0M | $537.1M | $952.4M | $253.5M | $113.7M | $74.5M | $66.2M | $49.8M | $39.0M | $40.7M | $31.9M | $23.4M | $17.8M | $22.4M | ||
| Restricted Cash And Cash Equivalents At Carrying Value | $5.2M | $8.3M | $10.9M | $9.2M | $3.2M | $0.00 | $1.5M | $3.0M | $1.6M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$76.1M | -$241.4M | -$1.90B | $592.6M | $1.7M | $64.2M | -$1.3M | $27.8M | -$24.2M | $5.3M | $14.4M | $17.3M | $613.0K | $58.2M | $5.3M |
| Investing Cash Flow * | -$2.92B | -$5.76B | -$3.02B | -$204.8M | -$42.5M | -$25.3M | -$11.9M | -$11.8M | -$4.5M | -$11.0M | -$5.2M | -$16.2M | -$13.8M | -$19.2M | -$11.7M |
| Operating Cash Flow * | $104.0M | -$770.7M | $15.35B | $479.3M | $39.1M | $7.9M | $59.8M | -$13.9M | $4.2M | -$10.1M | $5.6M | -$16.3M | $13.9M | -$14.3M | $48.4M |
| Share Based Compensation | $0.00 | $0.00 | $7.7M | $10.2M | $3.0M | $4.3M | $979.0K | $2.4M | $952.0K | $287.0K | $281.0K | $347.0K | $206.0K | $459.9K | $422.9K |
| Proceeds From Issuance Of Common Stock | $676.0K | $0.00 | $1.0M | $2.0M | $0.00 | $85.3M | $1.3M | $315.0K | $732.0K | $512.0K | $814.0K | $508.0K | $749.0K | $62.3M | $697.3K |
| Proceeds From Government Grants | $12.5M | $14.8M | $4.3M | $16.5M | $1.5M | $3.8M | $2.6M | $6.9M | $544.0K | $3.5M | $842.0K | $2.4M | $1.6M | $372.0K | $1.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$3.3M | -$22.5M | $143.3M | $13.2M | -$2.6M | $2.6M | $622.0K | $436.0K | -$434.0K | $506.0K | -$243.0K | -$913.0K | $531.0K | $903.7K | -$468.8K |
| Increase Decrease In Inventories | $16.8M | -$30.4M | $334.1M | $77.7M | $3.7M | $9.4M | $5.5M | $3.0M | -$28.0K | $6.1M | $7.2M | $426.0K | $1.9M | $8.6M | $5.4M |
| Increase Decrease In Accrued Income Taxes Payable | $101.4M | -$1.28B | $1.22B | $31.8M | $4.9M | -$11.8M | $4.9M | $1.7M | $576.0K | $899.0K | $7.0K | -$3.1M | $1.3M | -$5.5M | $6.8M |
| Increase Decrease In Accounts Receivable | -$82.1M | -$289.6M | $710.4M | $128.0M | $40.2M | $13.1M | $13.5M | $15.1M | -$41.0K | $9.7M | $7.3M | $4.3M | -$5.5M | -$1.0M | $5.0M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $109.4M | -$86.9M | $720.9M | $131.8M | $6.8M | -$6.2M | $33.4M | $2.7M | -$298.0K | -$3.5M | $4.5M | -$967.0K | $1.2M | -$686.5K | $5.1M |
| Proceeds From Sale Of Property Plant And Equipment | $39.0K | $608.0K | $172.0K | $20.0K | $21.0K | $22.0K | $19.0K | $26.0K | $81.0K | $0.00 | $0.00 | $5.0K | $122.0K | $231.6K | |
| Proceeds From Issuance Of Debt | $243.4M | $151.0K | $13.5M | $33.2M | $2.1M | $18.9M | $28.6M | $45.5M | $21.3M | $17.8M | $16.8M | $16.8M | $11.4M | ||
| Payments To Acquire Property Plant And Equipment | $719.8M | $127.5M | $10.6M | $5.6M | $11.9M | $12.7M | $5.3M | $10.9M | $5.1M | $16.2M | $15.5M | $24.8M | $4.3M | ||
| Increase Decrease In Deferred Liabilities | $2.5M | -$892.0K | $987.0K | -$5.0M | -$3.6M | $601.0K | -$675.0K | $1.0M | -$2.7M | $426.0K | $12.7M | ||||
| Increase Decrease In Other Noncurrent Liabilities | -$3.0M | -$440.0K | -$1.2M | -$1.2M | $28.0K | $330.0K | $339.0K | $779.0K | $932.0K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.06 | $1.00 | $74.27 | $0.97 | $0.41 | $0.34 | $0.45 | -$0.01 | -$0.03 | -$0.03 | $0.13 | -$0.27 | -$0.02 | -$0.16 | $0.46 |
| Weighted Average Number Of Shares Outstanding Basic | 99.6M | 99.5M | 99.3M | 98.9M | 94.9M | 64.7M | 57.0M | 56.9M | 56.3M | 55.7M | 55.3M | 54.9M | 54.6M | 53.1M | 42.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 99.6M | 114.2M | 114.0M | 113.7M | 109.7M | 65.0M | 57.1M | 56.9M | 56.3M | 56.1M | 55.8M | 54.9M | 54.6M | 53.1M | 43.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Earnings Per Share Basic | $-1.06 | $1.08 | $85.20 | $1.06 | $0.42 | $0.34 | $0.45 | $-0.01 | $-0.03 | $-0.03 | $0.13 | $-0.02 | $-0.16 | $0.47 | |
| Preferred Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 99.6M | 99.5M | 99.5M | 99.3M | 98.9M | 71.1M | 57.3M | 57.0M | 56.9M | 55.8M | 55.6M | 55.1M | 54.8M | 54.3M | |
| Common Stock Shares Issued | 99.6M | 99.5M | 99.5M | 99.3M | 98.9M | 71.1M | 57.3M | 57.0M | 56.9M | 55.8M | 55.6M | 55.1M | 54.8M | 54.3M | |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | |
| Proceeds From Stock Options Exercised With Shares Issued Subsequent To Year End | 0.00 | 0.00 | 64.0K | 428.0K | 0.00 | 18.0K | 51.0K | 18.0K | 8.0K | 3.0K | |||||
| Preferred Stock Shares Outstanding | 14.6M | 14.6M | 14.6M | 14.6M | 14.6M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $85.1M | $190.8M | $102.6M | $1.9M | $2.0M | $2.0M | $1.2M | $731.0K | $1.2M | $2.7M | $2.2M | $2.4M | $1.4M | $1.1M | $143.5K |
| Stock Issued During Period Value Stock Options Exercised | $676.0K | $1.0M | $14.0M | $4.0K | $3.0K | $1.3M | $315.0K | $732.0K | $512.0K | $849.0K | $508.0K | $749.0K | $410.0K | $697.3K | |
| Provision For Doubtful Accounts | $2.6M | $4.3M | $3.0M | $2.6M | -$306.0K | $820.0K | $934.0K | $1.4M | -$49.0K | $329.0K | -$504.0K | -$874.0K | -$167.0K | ||
| Interest Paid Net | $5.3M | $1.1M | $2.8M | $1.0M | $717.0K | $1.5M | $1.3M | $1.7M | $1.7M | $3.2M | $2.9M | $750.0K | $456.0K | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $7.7M | $10.2M | $3.0M | $4.3M | $979.0K | $2.4M | $952.0K | $287.0K | $281.0K | $347.0K | $206.0K | $459.9K | $422.9K | ||
| Rent Expenses Incurred To Related Party | $778.0K | $819.0K | $851.0K | $798.0K | $811.0K | $810.0K | $793.0K | $807.0K | $852.0K | $869.0K | $847.0K | $823.0K | $805.0K | ||
| Amortization Of Land Use Right | $2.2M | $1.7M | $2.2M | $238.0K | $238.0K | $249.0K | $243.0K | $247.0K | $261.0K | $267.0K | $311.0K | $299.0K | $285.0K | ||
| Prepaid Expense Noncurrent | $24.0K | $23.0K | $25.0K | $25.0K | $23.0K | $23.0K | $25.0K | $23.0K | $25.0K | $3.0K | $154.0K | $290.0K | $408.7K | $518.0K | |
| Transfer To Statutory Surplus Reserves | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Most recent annual filing with the SEC: April 29, 2024
Data sourced from SEC EDGAR public filings as of August 5, 2026.